ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA)
CUSIP: 488445206
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 56,066,823
- Total 13F shares
- 28,925,387
- Share change
- +12,563,463
- Total reported value
- $200,746,422
- Put/Call ratio
- 41%
- Price per share
- $6.94
- Number of holders
- 105
- Value change
- +$88,219,086
- Number of buys
- 62
- Number of sells
- 30
Quarterly Holders Quick Answers
What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 488445206:
Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Samuel J. Braun |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,153,000
|
$15,636,043 | — | 13 May 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.8%
|
2,697,052
|
$13,215,555 | — | 30 Jun 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
4.3%
|
2,419,435
|
$11,855,232 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
1,833,415
|
$8,983,733 | — | 30 Jun 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
2.1%
|
1,162,416
|
$5,695,838 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
2%
|
1,147,583
|
$5,623,157 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
914,264
|
$4,480,295 | — | 30 Jun 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.4%
|
800,000
|
$3,920,000 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
719,859
|
$3,527,309 | — | 30 Jun 2024 | |
| Retirement Planning Co of New England, Inc. |
13F
|
Company |
0.82%
|
458,300
|
$2,245,670 | — | 30 Jun 2024 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.77%
|
432,824
|
$2,121,000 | — | 30 Jun 2024 | |
| Mystic Asset Management, Inc. |
13F
|
Company |
0.53%
|
297,947
|
$1,459,940 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.52%
|
293,300
|
$1,437,171 | — | 30 Jun 2024 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.45%
|
253,700
|
$1,243,130 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.39%
|
220,499
|
$1,080,448 | — | 30 Jun 2024 | |
| AIGH Capital Management LLC |
13F
|
Company |
0.32%
|
181,673
|
$890,197 | — | 30 Jun 2024 | |
| Travis C. Mickle |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
171,774
|
$851,845 | — | 25 May 2022 | |
| Kovack Advisors, Inc. |
13F
|
Company |
0.27%
|
149,532
|
$732,707 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
138,504
|
$678,670 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
129,730
|
$635,677 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
112,800
|
$552,720 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
110,318
|
$540,558 | — | 30 Jun 2024 | |
| CREDIT AGRICOLE S A |
13F
|
Individual |
0.19%
|
106,000
|
$519,400 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.19%
|
105,238
|
$515,666 | — | 30 Jun 2024 | |
| Sanctuary Advisors, LLC |
13F
|
Company |
0.19%
|
104,924
|
$474,256 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
95,143
|
$466,201 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.16%
|
91,118
|
$446,478 | — | 30 Jun 2024 | |
| Sven Guenther |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
79,000
|
$391,769 | — | 31 Jan 2024 | |
| Christal M. M. Mickle |
3/4/5
|
Chief Development Officer |
—
class O/S missing
|
77,000
|
$381,851 | — | 31 Jan 2024 | |
| Arete Wealth Advisors, LLC |
13F
|
Company |
0.14%
|
78,413
|
$374,000 | — | 30 Jun 2024 | |
| Stratos Wealth Partners, LTD. |
13F
|
Company |
0.13%
|
70,240
|
$344,176 | — | 30 Jun 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.12%
|
69,197
|
$339,000 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
62,639
|
$306,931 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.1%
|
56,874
|
$278,675 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
45,070
|
$220,844 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.07%
|
39,764
|
$194,844 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
34,480
|
$168,952 | — | 30 Jun 2024 | |
| STRS OHIO |
13F
|
Company |
0.06%
|
34,400
|
$168,560 | — | 30 Jun 2024 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.06%
|
31,953
|
$156,570 | — | 30 Jun 2024 | |
| GTS SECURITIES LLC |
13F
|
Company |
0.06%
|
31,740
|
$155,526 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
30,469
|
$149,298 | — | 30 Jun 2024 | |
| Richard W. Pascoe |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
29,973
|
$148,639 | — | 09 Mar 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.05%
|
29,228
|
$143,000 | — | 30 Jun 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.05%
|
28,272
|
$138,533 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
27,892
|
$136,671 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
27,381
|
$134,166 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.05%
|
25,944
|
$127,126 | — | 30 Jun 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.04%
|
22,631
|
$110,892 | — | 30 Jun 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.04%
|
21,149
|
$103,630 | — | 30 Jun 2024 | |
| IFG Advisors, LLC |
13F
|
Company |
0.03%
|
18,700
|
$91,630 | — | 30 Jun 2024 |
Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) as of Q3 2024
As of 30 Sep 2024,
ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,925,387 shares.
The largest 10 holders included
Woodline Partners LP, BlackRock, Inc., Nantahala Capital Management, LLC, VANGUARD GROUP INC, FMR LLC, Altium Capital Management LP, 683 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, J. Goldman & Co LP, and STATE STREET CORP.
This page lists
105
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
92
Q3 2024 holders
105
Holder diff
13
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.